Clinical trials of viloxazine in depressive states
Fontan, M.; Goudemand, M.; Pellerin-Millecamps, E.
L'Encephale 5(3): 243-249
1979
ISSN/ISBN: 0013-7006 PMID: 385296 Document Number: 154000
Document emailed within 1 workday
Related Documents
Pchelina, A.L. 1980: Clinical picture of protracted depressive and depressive-paranoid states Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 80(9): 1371-1376Haehn, K.D. 1985: Treatment of depressive conditions with viloxazine by the general practitioner Fortschritte der Medizin 103(15): 408-412
Lennox, I.G.; Asbury, J.F.; Couldrick, W.G.; Beswick, K.B. 1978: Viloxazine and amitriptyline in depressive illness. a double blind controlled trial in general practice Practitioner 220(1315): 153-156
1972: Depressive states. Clinical and psychometric results Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 17: Suppl. 1: 26-8
Brasseur, R. 1972: Value of Déanxit in the ambulatory treatment of depressive states. Clinical study of 205 cases Schweizerische Rundschau für Medizin Praxis 61(37): 1153-1156
Bilikiewicz, A.; Nowicki, Z. 1970: Treatment of schizophrenized depressive states based on our personal clinical studies Psychiatria Polska 4(4): 443-448
Miller, C.A.; Hooper, C.L.; Bakish, D. 1997: A comparison of patients with major depressive disorder recruited through newspaper advertising versus consultation referrals for clinical drug trials Psychopharmacology Bulletin 33(1): 69-73
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Goldstein, H.A.; Pfennig, D. 1989: Clinical trials with iotrolan in myelographic and computed tomography applications in the United States Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband 128: 167-170
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Amin, M.M.; Ban, T.A.; Lehmann, H.E.; Khan, P. 1978: Viloxazine in the treatment of depression: psychophysical measures and clinical response Psychopharmacology Bulletin 14(1): 33-35
Browne, T.R. 1993: Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods Epilepsy Research. Suppl 10: 31-44
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Bourgeois, M.M. 1972: Depressive states Bordeaux Medical 5(3): 279-286
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518